Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A medicine for treating zoster sequela neuralgia

A technology for postherpetic neuralgia and herpes zoster, applied in drug combinations, nervous system diseases, pharmaceutical formulations, etc., can solve the problems of unsatisfactory curative effect, restricting clinical application, and far from effectively relieving the quality of life of patients with pain , to achieve the effects of low incidence of adverse reactions, improvement of clinical symptoms, and pain relief

Inactive Publication Date: 2010-01-27
邢怀广 +2
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine generally adopts antiviral, anti-inflammatory and analgesic and glucocorticoid drugs for treatment, and some people use carbamazepine or polyfiltrate for treatment, but the curative effect is not satisfactory, and there are gastrointestinal irritation, secondary infection, neurological symptoms, etc. Systemic and other adverse reactions, hypertension, diabetes, pregnancy, breast-feeding patients and many other problems restrict its clinical application, and it is far from achieving the purpose of effectively relieving pain and improving the quality of life of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0036] Example 1: A kind of medicine for the treatment of postherpetic neuralgia, the crude drug of making active ingredient is according to following weight: Bupleurum 10g, Polygonum cuspidatum 20g, Lonicera vine 30g, Toosendan 6g, Rhizoma 10g, Salvia miltiorrhiza 15g, fried white mustard seeds 6g, Xu Changqing 10g, Pittosporin 10g, Caulis Spatholobus 15g, Noctilucia 15g, scorpion 3g, centipede 2 (5g), licorice 6g.

[0037] Preparation and use method: Grind scorpion and centipede into fine powder respectively; one dose of other raw materials, decoct twice according to the routine, and mix the two times of liquid medicine to obtain a medicinal juice of about 300ml; the medicinal juice and the aforementioned fine powder of scorpion and centipede are as early as , Take it twice in the evening, one dose a day.

example 2

[0038] Example 2: A kind of medicine for the treatment of postherpetic neuralgia, the crude drug of active ingredient is made into following weights: Bupleurum 15g, Polygonum cuspidatum 20g, Lonicerae vine 25g, Toosendan 8g, Rhizoma 15g, Salvia miltiorrhiza 25g, fried white mustard seeds 7g, Xu Changqing 18g, Pittosporin 12g, Caulis Spatholobus 18g, Nocturna vine 18g, scorpion 4g, centipede 1 (4g), licorice 8g.

[0039] Preparation and usage method: Same as Example 1.

example 3

[0040] Example three: a kind of medicine for the treatment of postherpetic neuralgia, the crude drug that makes active ingredient is according to following weight: Bupleurum bupleuri 12g, Polygonum cuspidatum 21g, Lonicerae vine 28g, Toosendan 9g, Radix chinensis 24g, Salvia miltiorrhiza 30g, fried white mustard seed 7g, Xu Changqing 18g, Pittosporum piscifolia 12g, Caulis Spatholobus 18g, Nocturna vine 18g, scorpion 4g, centipede 1 (3g), licorice 8g.

[0041] Preparation and usage method: Same as Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating postherpetic neuralgia, and belongs to Chinese medicine preparation. The invention is characterized in that the raw materials for producing the effective components of the medicine have the following part by weight: bupleurum root is 10 to 15 parts, giant knotweed is 10 to 20 parts, honey-suckle stem is 15 to 30 parts, toosendan fruit is 6 to 10 parts, rhizoma corydalis is 10 to 24 parts, red sage root is 15 to 30 parts, parched Brassica alba boiss is 6 to 10 parts, root of swallowwort is 10 to 24 parts, bark of himalayan coralbean is 10 to 15 parts, lentherleaf millettia is 15 to 24 parts, fleece-flower stem is 15 to 24 parts, scorpion is 3 to 6 parts, centipede is 3 to 6 parts, and licorice root is 6 to 10 parts. The medicines are combined together to play the functions of eliminating dampness and heat, clearing away remaining poisonous influence, resolving phlegm and removing dampness, promoting flow of qi and blood circulation and activating the channels and relieving pains. The medicine can rapidly and effectively relieve the postherpetic neuralgia, improve other clinical symptoms and the adverse effects brought by the disease to the body and the spirit of a patient, with the total effectiveness ratio of up to 98.33 percent.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating postherpetic neuralgia. Background technique [0002] Herpes zoster is a common disease caused by varicella zoster virus, a neurotropic virus that often causes severe neuralgia, and the pain becomes worse with age. Some patients, especially middle-aged and elderly patients, often leave intractable neuralgia after herpes subsides, which lasts for several months or even longer; it brings great pain to patients and affects normal work and life. Western medicine generally adopts antiviral, anti-inflammatory and analgesic and glucocorticoid drugs for treatment, and some people use carbamazepine or polyfiltrate for treatment, but the curative effect is not satisfactory, and there are gastrointestinal irritation, secondary infection, neurological symptoms, etc. Systemic and other adverse reactions and many problems such as high blood pressure, diabet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/704A61K36/66A61K36/58A61K36/53A61K36/486A61K36/484A61K36/48A61K36/355A61K36/31A61K36/27A61K36/233A61K35/64A61P25/02A61P31/22A61K35/646A61K35/648
Inventor 邢怀广姜雯肖爱华
Owner 邢怀广
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com